MDS wishes to acknowledge the following Diamond Level supporter of the 2026 International Congress: Bayer / AskBio Inc. / BlueRock Therapeutics. #MDSCongress
October 3, 2026 at 3:00 AM
MDS wishes to acknowledge the following Diamond Level supporter of the 2026 International Congress: Bayer / AskBio Inc. / BlueRock Therapeutics. #MDSCongress
If you have Instagram / TikTok / YouTube… why keep all your links in different places? 👀
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
Ask | ASK (@askadmin)
Ask ASK anything, discover their links, and read their answers on Ask.
askbio.io
September 29, 2026 at 1:39 AM
If you have Instagram / TikTok / YouTube… why keep all your links in different places? 👀
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
If you have Instagram / TikTok / YouTube… why keep all your links in different places? 👀
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
Ask | ASK (@askadmin)
Ask ASK anything, discover their links, and read their answers on Ask.
askbio.io
September 29, 2026 at 1:38 AM
If you have Instagram / TikTok / YouTube… why keep all your links in different places? 👀
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
If you have Instagram / TikTok / YouTube… why keep all your links in different places? 👀
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
Ask | ASK (@askadmin)
Ask ASK anything, discover their links, and read their answers on Ask.
askbio.io
September 29, 2026 at 1:39 AM
If you have Instagram / TikTok / YouTube… why keep all your links in different places? 👀
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
If you have Instagram / TikTok / YouTube… why keep all your links in different places? 👀
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
Ask | ASK (@askadmin)
Ask ASK anything, discover their links, and read their answers on Ask.
askbio.io
September 29, 2026 at 1:39 AM
If you have Instagram / TikTok / YouTube… why keep all your links in different places? 👀
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
If you have Instagram / TikTok / YouTube… why keep all your links in different places? 👀
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
Ask | ASK (@askadmin)
Ask ASK anything, discover their links, and read their answers on Ask.
askbio.io
September 29, 2026 at 1:39 AM
If you have Instagram / TikTok / YouTube… why keep all your links in different places? 👀
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
#LinkInBio #ContentCreators #CreatorTools #PersonalBranding #AskBio
If you have Instagram / TikTok / YouTube… why keep all your links in different places? 👀
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
Ask | ASK (@askadmin)
Ask ASK anything, discover their links, and read their answers on Ask.
askbio.io
September 29, 2026 at 1:36 AM
If you have Instagram / TikTok / YouTube… why keep all your links in different places? 👀
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
Create your own Link in Bio + let your followers ask you questions on AskBio 🔥
Try it here 👇
askbio.io/askadmin
AskBio's umiposgene parvec Phase 2 heart failure trial hit 170 patients across 64 sites. Efficacy readout due H1 2027. Baseline data presented at ESC 2026.
AskBio presents GenePHIT Phase 2 baseline data at ESC 2026
AskBio's umiposgene parvec heart failure gene therapy trial enrolled over 170 patients across 64 sites; efficacy data are expected in H1 2027.
biotech.disruptsmedia.com
September 1, 2026 at 12:30 PM
AskBio's umiposgene parvec Phase 2 heart failure trial hit 170 patients across 64 sites. Efficacy readout due H1 2027. Baseline data presented at ESC 2026.
Signal or noise? > Bayer’s AskBio completes enrollment in Phase 2 heart failure
gene therapy trial (BAYZF:OTCMKTS) - Seeking Alpha >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #competitivemarketing #pharma #biotech
gene therapy trial (BAYZF:OTCMKTS) - Seeking Alpha >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #competitivemarketing #pharma #biotech
Bayer’s AskBio completes enrollment in Phase 2 heart failure
gene therapy trial (BAYZF:OTCMKTS) - Seeking Alpha
Bayer’s AskBio completes enrollment in Phase 2 heart failure gene therapy trial (BAYZF:OTCMKTS) Seeking Alpha
dlvr.it
August 30, 2026 at 8:22 PM
Signal or noise? > Bayer’s AskBio completes enrollment in Phase 2 heart failure
gene therapy trial (BAYZF:OTCMKTS) - Seeking Alpha >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #competitivemarketing #pharma #biotech
gene therapy trial (BAYZF:OTCMKTS) - Seeking Alpha >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #competitivemarketing #pharma #biotech
Signal or noise? > AskBio Presents Baseline Characteristics from Phase 2 Heart
Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at
European Society of… >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #healthcare #biotech #pharma #pharmaceutical
Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at
European Society of… >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #healthcare #biotech #pharma #pharmaceutical
AskBio Presents Baseline Characteristics from Phase 2 Heart
Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at
European Society of Cardiology Congress -
lincolnjournal.com
AskBio Presents Baseline Characteristics from Phase 2 Heart Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at European Society of Cardiology Congress lincolnjournal.com
dlvr.it
August 29, 2026 at 10:22 PM
Signal or noise? > AskBio Presents Baseline Characteristics from Phase 2 Heart
Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at
European Society of… >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #healthcare #biotech #pharma #pharmaceutical
Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at
European Society of… >> Comment below! #strategy #competitiveintelligence #marketing #competitivemarketing #healthcare #biotech #pharma #pharmaceutical
Signal or noise? > AskBio Presents Baseline Characteristics from Phase 2 Heart
Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at
European Society of… >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #biotech #competitivemarketing #pharma
Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at
European Society of… >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #biotech #competitivemarketing #pharma
AskBio Presents Baseline Characteristics from Phase 2 Heart
Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at
European Society of Cardiology Congress - Carroll County
Mirror-Democrat
AskBio Presents Baseline Characteristics from Phase 2 Heart Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at European Society of Cardiology Congress Carroll County Mirror-Democrat
dlvr.it
August 29, 2026 at 6:53 PM
Signal or noise? > AskBio Presents Baseline Characteristics from Phase 2 Heart
Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at
European Society of… >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #biotech #competitivemarketing #pharma
Failure Gene Therapy Trial of Umiposgene Parvec (AB-1002) at
European Society of… >> Comment below! #strategy #competitiveintelligence #marketing #healthcare #pharmaceutical #biotech #competitivemarketing #pharma
“Do not compare yourselves to others. Focus on your own journey, your own data, and your own development.” Interview of MolBio grad alum and AskBio CSO Mansuo Shannon *98 leading up to the Princeton Alumni Many Minds, Many Stripes conference. molbio.princeton.edu/news/2025/ma...
Mansuo Shannon *98, Chief Science Officer, AskBio
“Do not compare yourselves to others. It is so easy to compare yourself to everyone around you, especially in the current technological age. But everyone's project is different, everyone's timeline is...
molbio.princeton.edu
August 18, 2025 at 8:12 PM
“Do not compare yourselves to others. Focus on your own journey, your own data, and your own development.” Interview of MolBio grad alum and AskBio CSO Mansuo Shannon *98 leading up to the Princeton Alumni Many Minds, Many Stripes conference. molbio.princeton.edu/news/2025/ma...
Multiple System Atrophy Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline | Theravance Biopharma, Alterity Therapeutics, AskBio, Kainos Medicines, CORESTEM,
Multiple System Atrophy Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline | Theravance Biopharma, Alterity Therapeutics, AskBio, Kainos Medicines, CORESTEM, | PressReleaseCC
DelveInsight reports that over 20 key companies are actively developing more than 22 therapies for the treatment of Multiple System Atrophy.
www.pressreleasecc.com
November 29, 2025 at 6:13 PM
Multiple System Atrophy Clinical Trials, Companies, Therapeutic Assessment, Therapies, Treatment Algorithm, Pipeline | Theravance Biopharma, Alterity Therapeutics, AskBio, Kainos Medicines, CORESTEM,
@genethonfr.bsky.social annonce avoir conclu un accord de licence avec AskBio pour le développement d'une thérapie génique pour traiter la maladie de Pompe.
👉 www.genethon.fr/genethon-con...
#pompe #partenariat #therapiegenique
👉 www.genethon.fr/genethon-con...
#pompe #partenariat #therapiegenique
Généthon conclut un accord de licence avec AskBio pour le développement d’une thérapie génique expérimentale pour le traitement de la maladie de Pompe
Généthon, laboratoire leader de la thérapie génique pour les maladies rares, annonce aujourd’hui avoir conclu avec AskBio, société dédiée à la thérapie génique détenue à 100% et gérée de manière indép...
www.genethon.fr
January 14, 2026 at 10:32 AM
@genethonfr.bsky.social annonce avoir conclu un accord de licence avec AskBio pour le développement d'une thérapie génique pour traiter la maladie de Pompe.
👉 www.genethon.fr/genethon-con...
#pompe #partenariat #therapiegenique
👉 www.genethon.fr/genethon-con...
#pompe #partenariat #therapiegenique
📢 @genethonfr.bsky.social signs licensing agreement with AskBio for the development of a gene therapy for Pompe Disease.
👉Full press release : urlr.me/D7huUr
#innovation #licensing #genetherapy #pompe
👉Full press release : urlr.me/D7huUr
#innovation #licensing #genetherapy #pompe
Genethon Signs Licensing Agreement with AskBio for the Development of an Investigational Gene Therapy for Pompe Disease
Genethon, a leading laboratory in gene therapy for rare diseases, today announced that it has entered into an exclusive, worldwide licensing agreement with AskBio, a gene therapy company wholly owned ...
urlr.me
January 14, 2026 at 10:30 AM
📢 @genethonfr.bsky.social signs licensing agreement with AskBio for the development of a gene therapy for Pompe Disease.
👉Full press release : urlr.me/D7huUr
#innovation #licensing #genetherapy #pompe
👉Full press release : urlr.me/D7huUr
#innovation #licensing #genetherapy #pompe
Roche launches new Boston center; NIH centralizes peer review www.biopharmadive.com/news/roche-b...
Roche launches new Boston center; NIH centralizes peer review
The Swiss pharma will base cardiometabolic drug research at the new Allston site. Elsewhere, AskBio advanced a gene therapy and Pfizer hired a scientist well versed in GLP-1 science.
www.biopharmadive.com
March 10, 2025 at 2:04 AM
Roche launches new Boston center; NIH centralizes peer review www.biopharmadive.com/news/roche-b...
2/2
🎤 Keynote speakers:
Kathleen Börner (AskBio GmbH)
Kai Dallmeier (KU Leuven)
Michael Mühlebach (Paul-Ehrlich-Institut)
Ralf Wagner (University of Regensburg)
📆 Registration & abstract deadline: September 30, 2025
🔗 viralvectors.g-f-v.org
We look forward to welcoming you in Erlangen!
🎤 Keynote speakers:
Kathleen Börner (AskBio GmbH)
Kai Dallmeier (KU Leuven)
Michael Mühlebach (Paul-Ehrlich-Institut)
Ralf Wagner (University of Regensburg)
📆 Registration & abstract deadline: September 30, 2025
🔗 viralvectors.g-f-v.org
We look forward to welcoming you in Erlangen!
Arbeitskreis Virale Vektoren | Arbeitskreis der Gesellschaft für Virologie
viralvectors.g-f-v.org
July 21, 2025 at 6:47 AM
2/2
🎤 Keynote speakers:
Kathleen Börner (AskBio GmbH)
Kai Dallmeier (KU Leuven)
Michael Mühlebach (Paul-Ehrlich-Institut)
Ralf Wagner (University of Regensburg)
📆 Registration & abstract deadline: September 30, 2025
🔗 viralvectors.g-f-v.org
We look forward to welcoming you in Erlangen!
🎤 Keynote speakers:
Kathleen Börner (AskBio GmbH)
Kai Dallmeier (KU Leuven)
Michael Mühlebach (Paul-Ehrlich-Institut)
Ralf Wagner (University of Regensburg)
📆 Registration & abstract deadline: September 30, 2025
🔗 viralvectors.g-f-v.org
We look forward to welcoming you in Erlangen!
It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene therapies.
After selling at a peak, AskBio now wants to make $4 billion price tag a bargain
It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene therapies.
bit.ly
January 12, 2026 at 6:30 PM
It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene therapies.
It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene therapies.
RTP’s AskBio wants to make $4 billion price tag look like a bargain
It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene therapies.
bit.ly
January 12, 2026 at 11:40 AM
It was the priciest biotech startup sale in North Carolina history. Now five years under Bayer, AskBio advances more AAV gene therapies.
Other key subsidiaries and brands include BlueRock Therapeutics, Asklepios BioPharmaceutical (AskBio), The Climate Corporation, Consumer Health brands (e.g., Claritin, Alka-Seltzer, One-A-Day), and various pharmaceutical brands like Bayer HealthCare.
April 28, 2026 at 3:10 PM
Other key subsidiaries and brands include BlueRock Therapeutics, Asklepios BioPharmaceutical (AskBio), The Climate Corporation, Consumer Health brands (e.g., Claritin, Alka-Seltzer, One-A-Day), and various pharmaceutical brands like Bayer HealthCare.
